|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immune system
|
 |
|
Title:
|
 |
Structure of an ignar-ama1 complex
|
|
Structure:
|
 |
Apical membrane antigen 1. Chain: a, b. Fragment: domain i, ii, unp residues 104-438. Engineered: yes. New antigen receptor variable domain. Chain: c, d. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Plasmodium falciparum. Organism_taxid: 36329. Strain: 3d7. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008. Orectolobus maculatus. Spotted wobbegong. Organism_taxid: 168098. Expressed in: escherichia coli.
|
|
Resolution:
|
 |
|
2.35Å
|
R-factor:
|
0.210
|
R-free:
|
0.285
|
|
|
Authors:
|
 |
V.A.Streltsov,K.A.Henderson,A.H.Batchelor,A.M.Coley,S.D.Nuttall
|
Key ref:
|
 |
K.A.Henderson
et al.
(2007).
Structure of an IgNAR-AMA1 complex: targeting a conserved hydrophobic cleft broadens malarial strain recognition.
Structure,
15,
1452-1466.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
11-Sep-07
|
Release date:
|
27-Nov-07
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Structure
15:1452-1466
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of an IgNAR-AMA1 complex: targeting a conserved hydrophobic cleft broadens malarial strain recognition.
|
|
K.A.Henderson,
V.A.Streltsov,
A.M.Coley,
O.Dolezal,
P.J.Hudson,
A.H.Batchelor,
A.Gupta,
T.Bai,
V.J.Murphy,
R.F.Anders,
M.Foley,
S.D.Nuttall.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Apical membrane antigen 1 (AMA1) is essential for invasion of erythrocytes and
hepatocytes by Plasmodium parasites and is a leading malarial vaccine candidate.
Although conventional antibodies to AMA1 can prevent such invasion, extensive
polymorphisms within surface-exposed loops may limit the ability of these
AMA1-induced antibodies to protect against all parasite genotypes. Using an
AMA1-specific IgNAR single-variable-domain antibody, we performed targeted
mutagenesis and selection against AMA1 from three P. falciparum strains. We
present cocrystal structures of two antibody-AMA1 complexes which reveal
extended IgNAR CDR3 loops penetrating deep into a hydrophobic cleft on the
antigen surface and contacting residues conserved across parasite species.
Comparison of a series of affinity-enhancing mutations allowed dissection of
their relative contributions to binding kinetics and correlation with inhibition
of erythrocyte invasion. These findings provide insights into mechanisms of
single-domain antibody binding, and may enable design of reagents targeting
otherwise cryptic epitopes in pathogen antigens.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 5.
Figure 5. V[NAR]-AMA1 Contacts (A) Alignment of AMA1s
from P. falciparum strains 3D7, W2mef, and HB3 (residues
N104–E438). Residues polymorphic between strains are boxed.
Conserved hydrophobic cleft residues are underlined and
asterisked. Residues in contact with V[NAR]s 14I-1 and 14I1-M15
(magenta), 14I-1 only (red), or 14I1-M15 only (blue) are
indicated. (B) Stereo images of the 14I-1 backbone (red)
penetrating the AMA1 hydrophobic cleft (gray). Side chains of
AMA1 residues within 4 Å of the V[NAR] backbone are shown,
including hydrophobic residues forming the base of the
hydrophobic cleft (orange) and residues polymorphic between P.
falciparum strains 3D7, W2mef, and HB3 (cyan). (C) As for
(B) except for 14I1-M15 backbone (blue).
|
 |
Figure 6.
Figure 6. Mechanism of V[NAR] Binding (A) V[NAR] residue
Arg92 contacts AMA1 residues Asn173, Glu174, Pro185, Thr186, and
Glu187 (<4 Å) in a series of hydrogen bond and salt bridge
interactions in the 14I-1 crystallographic structure. Residue
coloring is as for Figure 5. (B) As for (A) except for the
V[NAR] 14I1-M15 structure. (C) V[NAR] residues Tyr94,
Tyr96, and Leu98 in the 14I-1 structure contact hydrophobic
cleft residues Phe183 and Tyr251, and associated residue Asn371,
through a network of water-mediated hydrogen bonds and potential
aromatic interactions. (D) V[NAR] residues Leu89 and Phe100
in the 14I-1 structure are closely associated with AMA1 residues
within the hydropobic cleft (Met190, Tyr202, Met224) and
residues polymorphic between P. falciparum strains (Met190,
Phe201).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Structure
(2007,
15,
1452-1466)
copyright 2007.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
H.González-Díaz,
F.Prado-Prado,
E.Sobarzo-Sánchez,
M.Haddad,
S.Maurel Chevalley,
A.Valentin,
J.Quetin-Leclercq,
M.A.Dea-Ayuela,
M.Teresa Gomez-Muños,
C.R.Munteanu,
J.José Torres-Labandeira,
X.García-Mera,
R.A.Tapia,
and
F.M.Ubeira
(2011).
NL MIND-BEST: a web server for ligands and proteins discovery--theoretic-experimental study of proteins of Giardia lamblia and new compounds active against Plasmodium falciparum.
|
| |
J Theor Biol,
276,
229-249.
|
 |
|
|
|
|
 |
M.Lamarque,
S.Besteiro,
J.Papoin,
M.Roques,
B.Vulliez-Le Normand,
J.Morlon-Guyot,
J.F.Dubremetz,
S.Fauquenoy,
S.Tomavo,
B.W.Faber,
C.H.Kocken,
A.W.Thomas,
M.J.Boulanger,
G.A.Bentley,
and
M.Lebrun
(2011).
The RON2-AMA1 Interaction is a Critical Step in Moving Junction-Dependent Invasion by Apicomplexan Parasites.
|
| |
PLoS Pathog,
7,
e1001276.
|
 |
|
|
|
|
 |
J.O.Conway,
L.J.Sherwood,
M.T.Collazo,
J.A.Garza,
and
A.Hayhurst
(2010).
Llama single domain antibodies specific for the 7 botulinum neurotoxin serotypes as heptaplex immunoreagents.
|
| |
PLoS One,
5,
e8818.
|
 |
|
|
|
|
 |
S.Hearty,
P.J.Conroy,
B.V.Ayyar,
B.Byrne,
and
R.O'Kennedy
(2010).
Surface plasmon resonance for vaccine design and efficacy studies: recent applications and future trends.
|
| |
Expert Rev Vaccines,
9,
645-664.
|
 |
|
|
|
|
 |
S.Jähnichen,
C.Blanchetot,
D.Maussang,
M.Gonzalez-Pajuelo,
K.Y.Chow,
L.Bosch,
S.De Vrieze,
B.Serruys,
H.Ulrichts,
W.Vandevelde,
M.Saunders,
H.J.De Haard,
D.Schols,
R.Leurs,
P.Vanlandschoot,
T.Verrips,
and
M.J.Smit
(2010).
CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells.
|
| |
Proc Natl Acad Sci U S A,
107,
20565-20570.
|
 |
|
|
|
|
 |
C.R.Collins,
C.Withers-Martinez,
F.Hackett,
and
M.J.Blackman
(2009).
An inhibitory antibody blocks interactions between components of the malarial invasion machinery.
|
| |
PLoS Pathog,
5,
e1000273.
|
 |
|
|
|
|
 |
J.Wesolowski,
V.Alzogaray,
J.Reyelt,
M.Unger,
K.Juarez,
M.Urrutia,
A.Cauerhff,
W.Danquah,
B.Rissiek,
F.Scheuplein,
N.Schwarz,
S.Adriouch,
O.Boyer,
M.Seman,
A.Licea,
D.V.Serreze,
F.A.Goldbaum,
F.Haag,
and
F.Koch-Nolte
(2009).
Single domain antibodies: promising experimental and therapeutic tools in infection and immunity.
|
| |
Med Microbiol Immunol,
198,
157-174.
|
 |
|
|
|
|
 |
L.Bloom,
and
V.Calabro
(2009).
FN3: a new protein scaffold reaches the clinic.
|
| |
Drug Discov Today,
14,
949-955.
|
 |
|
|
|
|
 |
M.Gebauer,
and
A.Skerra
(2009).
Engineered protein scaffolds as next-generation antibody therapeutics.
|
| |
Curr Opin Chem Biol,
13,
245-255.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |